By Lucia Osborne-Crowley ( September 25, 2025, 7:29 PM BST) -- Pfizer and BioNTech are suing GlaxoSmithKline Biologicals over a range of its patents linked to key processes in the manufacture of COVID-19 vaccines, arguing that the substances were not novel when GSK patented them....

See Full Page